Shares of BioLife Solutions, Inc. (BLFS) have gained 8.2% over the past four weeks to close the last trading session at $23.89, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$31.22 indicates a potential upside of 30.7%.The mean estimate comprises nine short-term price targets with a standard deviation of $1.48. While the lowest estimate of$30 indicates a 25.6% increase from t ...